HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recurrent Optic Neuritis Associated With MOG Antibody Seropositivity.

AbstractINTRODUCTION:
Optic neuritis (ON) can be the first manifestation of autoimmune central nervous system diseases such as multiple sclerosis and neuromyelitis optica, but it can also occur as an isolated monophasic or relapsing disease. A proportion of these patients have antibodies against myelin oligodendrocyte glycoprotein (MOG). We report a case of recurrent ON with MOG antibodies in a South Asian patient.
CASE REPORT:
A 50-year-old Sri Lankan female with a previous history of 2 episodes of steroid-responsive ON presented with a 20/120 visual impairment of her right eye. On examination on admission, visual acuity was noted to be 20/30 on the left and visual evoked potentials were prolonged bilaterally, but all other neurological investigations including screening tests for infections and vasculitis were unremarkable. AQP4 antibodies were negative but MOG antibodies were positive. She responded to intravenous and long-term steroids combined with mycophenolate mofetil, but relapsed when steroids were discontinued. She has been relapse free on low-dose steroids and mycophenolate for 2 years.
CONCLUSIONS:
Recurrent ON occurs in association with MOG antibodies distinct from neuromyelitis optica and multiple sclerosis, and may require steroid-based immunosuppression to maintain remission. This case report from South Asia adds to map the worldwide occurrence of MOG antibody disease.
AuthorsThashi Chang, Patrick Waters, Mark Woodhall, Angela Vincent
JournalThe neurologist (Neurologist) Vol. 22 Issue 3 Pg. 101-102 (May 2017) ISSN: 2331-2637 [Electronic] United States
PMID28471902 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Autoantibodies
  • Myelin-Oligodendrocyte Glycoprotein
Topics
  • Autoantibodies (blood, immunology)
  • Female
  • Humans
  • Middle Aged
  • Myelin-Oligodendrocyte Glycoprotein (blood, immunology)
  • Optic Neuritis (immunology)
  • Recurrence

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: